Key Partners Key Activities Value Propositions Customer Relationships Customer Segments

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

Value Customer Customer

Key Partners Key Activities Propositions Relationships Segments


Pharmaceutical Focusing on the Asset sharing like for Treatment failure is By Various
companies, health treatment of patients example, making often caused by Organizations within
care providers and with rare diseases. available clinical trial specificities in global life sciences and
various organizations To efficiently match databases that individual genomes, health care.
within global life treatments to rare record the and they realized
sciences & health disease patients. effectiveness of that their technology
care. drugs. could help
Revealing drug with companies predict
high potential for such failures with
treating the rare high accuracy. In the
diseases. long term it could
The Healx model empower patients by
would, in theory, giving them much
create a more information
collaborative before they consult a
ecosystem by medical practitioner.
Key Resources bringing the big Channels
pharma and health
They compared the care providers Recently they
amount of drug data together. developed a
currently provided to machine-learning
sufferers of rare algorithm that can
diseases. They use a patient's
measured asset biological
sharing by looking at information not only
the proportion of to match drugs to
known data on their disease symptoms
disease relevant drugs but also to predict
that they could access. exactly which drug
And they assessed its will achieve what
collaborative level of effectiveness
ecosystem by looking for a particular
at how many of the patient.
main data holding
institutions
participated.

Cost Structure Revenue Streams


If an expensive treatment does not work for a patient, the The treating clinician armed with the biological data and
company responsible can be forced to reimburse NHS the algorithm can make better treatment decisions
providers for its cost.  directly with the patient and doesn’t have to rely on
fixed rules of thumb about which of the few available
off-label drugs to use. In this way, Healx can support
decentralized, real-time, accurate decision making.
HEALX: A CASE STUDY
THE BUSINESS MODEL CANVAS

You might also like